A network for advancing genomics research and improving health
Official title: Helix Research Network
Run by Helix, Inc · NCT06057181 · Data updated 2026-11-12
This study is testing how sharing genetic information from patients can help doctors better understand diseases and improve treatments for everyone involved.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000000 (estimated) |
| Sponsor | Helix, Inc Industry-sponsored |
| Locations | 14 sites (Fort Wayne, Indiana and 13 other locations) |
| Status | Recruiting |
| Started | September 13, 2021 |
| Main results expected | September 13, 2031 |
| Study ends | September 13, 2036 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT06057181 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 18 and older who are willing to comply with the study protocol.
✕Probably not a fit
Patients with a history of allogenic bone marrow or stem cell transplants may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Helix Research Network is a collaborative initiative involving various healthcare organizations aimed at enhancing medical research through large-scale genomics. It focuses on creating a comprehensive clinicogenomics dataset to identify genetic and molecular factors influencing disease risk, progression, and treatment responses. Participants will undergo exome sequencing and receive annual reports on their health outcomes and the study's impact. The network aims to integrate genomic data into clinical care to improve diagnosis and treatment for individuals.
Why it matters
Potential benefit: If successful, this initiative could lead to more personalized and effective medical treatments based on genetic information.
How similar studies have gone: Other studies utilizing large-scale genomic data have shown promise in identifying disease risk factors and improving patient outcomes, indicating a favorable outlook for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years and older * Willing and able to comply with all aspects of the protocol Exclusion Criteria: * History of allogenic bone marrow transplant * History of allogenic stem cell transplant * Anything that would place the individual at increased risk or preclude an individual's: 1) full compliance with study requirements; or 2) completion of the study based on the assessment from local consenting and enrolling Investigators.
Where it's running
-
Parkview Health (DNA Insights)
Fort Wayne, Indiana, United States Recruiting -
HealthPartners (myGenetics)
Bloomington, Minnesota, United States Recruiting -
Nebraska Medicine - University of Nebraska Medical Center (Genetic Insights Project)
Omaha, Nebraska, United States Recruiting -
Renown Health (Healthy Nevada Project)
Reno, Nevada, United States Recruiting -
Rochester Regional Health (GenoWell)
Rochester, New York, United States Recruiting -
Cone Health (Gene Connect)
Burlington, North Carolina, United States Recruiting
Show 8 more locations
-
WakeMed (PreciselyYou)
Raleigh, North Carolina, United States Recruiting -
TriHealth (DNA Discovery)
Cincinnati, Ohio, United States Recruiting -
The Ohio State University (Genomic Health)
Columbus, Ohio, United States Recruiting -
St. Luke's University Health Network (DNAanswers)
Bethlehem, Pennsylvania, United States Recruiting -
WellSpan Health (The Gene Health Project)
York, Pennsylvania, United States Recruiting -
Medical University of South Carolina (In Our DNA SC)
Charleston, South Carolina, United States Recruiting -
Sanford Health (Imagine You)
Sioux Falls, South Dakota, United States Recruiting -
Memorial Hermann Health System (genoME)
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: William Lee, PhD — Helix, Inc
- Study coordinator: Layla Anderson
- Email: researchadmin@helix.com
- Phone: 206-295-8866
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sirolimus for ApoE4 Carriers: Testing Brain Blood Flow in Women 45-65
Researchers will test whether sirolimus can improve brain blood flow in healthy ApoE4-positive women ages 45 to 65 compared with a placebo.
-
Germline testing for inherited risk of myeloid blood cancers
This research will test whether a germline genetic test (MyeloGen Gene Panel) can find inherited changes linked to myeloid blood cancers in adults who have been diagnosed.
-
Examining the role of vaginal microbiome in ovarian cancer detection
This study is trying to see if the bacteria in the vagina can help detect ovarian cancer earlier by comparing samples from healthy women and those at higher risk or already diagnosed.
-
Using genetic profiling to improve cancer treatment
This study is testing if using genetic information can help doctors choose better treatments for cancer patients based on their specific tumor characteristics.
-
Molecular profiling and drug testing for pediatric acute myeloid leukemia
This study is trying to learn more about pediatric acute myeloid leukemia by looking at patients' cells to find out why some treatments don’t work and to test new drug options for kids and young adults with this cancer.
-
Assessing cardiovascular disease risks in the Ballana population
This study is trying to see how common heart disease is in the Ballana community in Egypt and what factors might increase the risk over the next 30 years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.